Artificial intelligence is rapidly advancing applications across biotech and healthcare. A novel AI-driven wearable from Empatica offers compact, high-quality monitoring for decentralized clinical trials with FDA clearance anticipated by 2025. DeepHealth completed a $110 million acquisition to bolster AI-powered cancer imaging tools. AI chatbots pose risks of misinformation, reinforcing the need for responsible deployment in medicine. Meanwhile, AI combined with infrared thermography enables early detection of health patterns in calves, showcasing veterinary utility. These developments underscore AI’s multifaceted impact in diagnostics, clinical monitoring, and drug discovery.